It was reported that the patient experienced a gastrointestinal (gi) bleed, dark feces, and some challenges with the biliary duct.Embozene microspheres (40 um) was selected for use during a liver embolization/bland-tace procedure for a patient with liver cancer.No malfunction was reported to have occurred during the procedure.However, afterwards, the doctor reported that the patient had an adverse event of gi bleed, dark feces and some challenges with the biliary duct; believed to be due to the embozene 40 um.No other complications were reported.
|